Prelude Capital Management, LLC Shockwave Medical, Inc. Transaction History

Prelude Capital Management, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $430,514 - $733,318	-2,252 Reduced 34.54%	4,268 $1.39 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $402,153 - $538,793	2,498 Added 62.11%	6,520 $1.24 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $394,878 - $577,027	2,032 Added 102.11%	4,022 $800,000
Q2 2023 Aug 14, 2023	SELL	$223.05 - $302.68 $967,590 - $1.31 Million	-4,338 Reduced 68.55%	1,990 $567,000
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $453,084 - $562,887	2,583 Added 68.97%	6,328 $1.37 Million
Q4 2022 Feb 14, 2023	BUY	$204.38 - $296.82 $45,985 - $66,784	225 Added 6.39%	3,745 $770,000
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $316,044 - $502,748	-1,619 Reduced 31.5%	3,520 $979,000
Q2 2022 Aug 15, 2022	SELL	$115.91 - $214.48 $630,202 - $1.17 Million	-5,437 Reduced 51.41%	5,139 $982,000
Q1 2022 May 16, 2022	BUY	$127.96 - $207.36 $1.35 Million - $2.19 Million	10,576 New	10,576 $2.19 Million
Q1 2020 May 15, 2020	SELL	$23.16 - $47.74 $1,065 - $2,196	-46 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$29.4 - $44.98 $1,352 - $2,069	46 New	46 $2,000

320K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Prelude Capital Management, LLC with notifications on news.